Hongrun Construction Group Co Ltd (002062.SZ) stock: key figures, P/E, revenue and dividend
Industrials · Construction & Engineering · China · ISIN CNE000001NH2
Hongrun Construction Group Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.92 bn CNY | 5.75 bn CNY |
| Gross profit | 974.56 m CNY | 731.70 m CNY |
| Operating income | 442.07 m CNY | 295.83 m CNY |
| EBIT | 448.76 m CNY | 402.36 m CNY |
| Net income | 282.92 m CNY | 279.69 m CNY |
| Diluted EPS – continuing operations | 0.26 CNY | 0.23 CNY |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hongrun Construction Group Co Ltd
Hongrun Construction Group Co., Ltd., together with its subsidiaries, engages in the construction business in China and internationally. It is involved in rail transit construction; municipal engineering; highway bridges; underground spaces; integrated pipe corridors; water and environmental protection; marine engineering; building construction; real estate development; infrastructure project investment and construction; and investment in high-tech industries, including green new energy, intelligent manufacturing, and robotics technology applications. The company also undertakes general contracting, engineering contracting, and project management for municipal public works, housing construction, highways, railways, ports and waterways, and water conservancy and hydropower projects; highway and electromechanical engineering; and professional contracting of building decoration and foundation engineering. In addition, it engages in property management and services; industrial investment; professional and technical services; transportation activities; and photovoltaic energy. The company was founded in 1994 and is headquartered in Shanghai, China.
More stocks
- SonoScape Medical Corp (300633.SZ)
- Lightspeed Commerce Inc (LSPD.TO)
- Guangdong Marubi Biotechnology Co (603983.SS)
- Vanchip (Tianjin) Technology Co. Ltd. A (688153.SS)
- Mezzion Pharma Co.Ltd (140410.KQ)
- Pacira BioSciences, Inc. (PCRX)
- PHIBRO ANIMAL HEALTH CORP (PAHC)
- Mayr-Melnhof Karton AG (MMK.VI)
- Huadian Ener-B (900937.SS)
- Pagaya Technologies Ltd. (PGY)
- Suzhou Betely Polymer Materials Co., Ltd. (301697.SZ)
- Glenveagh Properties PLC (GVR.IR)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.